Prosecution Insights
Last updated: October 02, 2026

Examiner: ALLEY, GENEVIEVE S

Tech Center 1600 • Art Units: 1611 1614 1617 1619

This examiner grants 60% of resolved cases

Analysis

Genevieve S Alley handles cases in Tech Center 1600 and Art Unit 1611. With 736 resolved cases, the allowance rate is 60.3 percent, showing a positive trend for applicants. This 60.3 percent rate indicates that the majority of the 736 cases are successful. The data reflects a stable prosecution environment.

The interview lift is 48.2 percent, which is a high figure that suggests interviews are extremely effective. The median days to allowance is 1066, which is a standard timeframe for reaching a grant. Practitioners should prioritize interviews to capitalize on the 48.2 percent lift and improve the 60.3 percent allowance rate. The 1066-day timeline provides a predictable schedule for reaching a resolution. These metrics indicate that direct communication with the examiner is a highly successful tactic for securing a patent grant in this art unit.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

60.3%
Allow Rate
At TC average
777
Total Applications
+48.2%
Interview Lift
1067
Avg Prosecution Days
Based on 736 resolved cases, 2023–2026

Rejection Statute Breakdown

1.4%
§101 Eligibility
14.2%
§102 Novelty
49.7%
§103 Obviousness
18.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18284625 NON-ELUTABLE ANTIMICROBIAL GLASS COMPOSITION, AND METHOD FOR PREPARING ANTIMICROBIAL GLASS POWDER USING SAME Non-Final OA LG ELECTRONICS INC.
18835879 METAL EFFECT PIGMENTS WITH SURFACE-TREATMENTS, PREPARING METHOD AND USE OF SAME Non-Final OA MERCK PATENT GmbH
18589817 SKIN PENETRATION IMPROVER Final Rejection KANEKA CORPORATION
18727863 POTASSIUM-SODIUM TARTRATE AS GRANULATING AID Non-Final OA BASF SE
18716697 Herbicidal Compositions Final Rejection Syngenta Crop Protection AG
18626620 NANO-DELIVERY SYSTEMS COMPRISING MODIFIED LIPIDS AND USE THEREOF Final Rejection TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
18721056 COMPOSITION COMPRISING HYDROPHOBICIZED POLYION COMPLEX PARTICLE Non-Final OA L'Oreal
18711436 COSMETIC COMPOSITION FOR CARING FOR THE SKIN Final Rejection L'OREAL
18600263 NANOFIBER AND MICROFIBER HYBRID AEROGELS Final Rejection Board of Regents of the University of Nebraska
17629854 ALGINATE-BASED FACIAL MASK Non-Final OA BEIERSDORF AG
18750592 NANOPARTICLE (NP)-ENHANCED EXPRESSION OF AQUAPORIN-4 CHANNELS AND WATER TRANSPORT IN HUMAN ASTROCYTES Final Rejection The Government of the United States of America, as represented by the Secretary of the Navy
18695864 EFFERVESCENT CLEANSING POWDER COMPOSITION Non-Final OA Conopco, Inc., d/b/a UNILEVER
18892456 Indane Derivatives for Malodor Counteraction Non-Final OA Firmenich SA
18579422 METHOD FOR THE PRODUCTION OF GRANULES COMPRISING A MAGNESIUM ION-COMPRISING MATERIAL Final Rejection Omya International AG
18711261 METHODS FOR INTRATUMORAL DELIVERY OF CRISPR/CAS SYSTEMS Non-Final OA Christiana Care Gene Editing Institute, Inc.
17714025 SILK FIBROIN-BASED MICRONEEDLES AND USES THEREOF Non-Final OA VAXESS TECHNOLOGIES, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month